Vaccines market expected to reach $57.5 billion by 2025
Vaccines Market By Indication (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR), Type (Live, Toxoid), Route Of Administration (IM, SC, Oral), Valence (Monovalent, Multivalent) And Geography–Global Forecast To 2025
(EMAILWIRE.COM, December 19, 2018 ) The global vaccines market is expected to reach $57,501.8 million by 2025 at a CAGR of 7.9%. The growth of this market is mainly attributed to high prevalence of diseases, increasing government initiatives towards immunization, rising adoption of vaccines, technological advancement in vaccine industry, and strong pipeline for vaccines.
Vaccines Market by Indication (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR), Type (Live, Toxoid), Route of Administration (IM, SC, Oral), Valence (Monovalent, Multivalent) And Geography – Global Forecast To 2025
Browse detailed TOC @ https://www.meticulousresearch.com/product/vaccines-market/
The global vaccines market is highly competitive with the presence of many players worldwide. With four big pharmaceutical companies; GSK, Merck & Co., Inc., Pfizer, and Sanofi, the vaccine industry is highly consolidated. CSL Limited, Emergent Biosolutions, Johnson and Johnson, Serum Institute of India, Daiichi Sankyo, Takeda and AstraZeneca are the other leading players of the global vaccines market. All these players are focusing more on technologically-advanced vaccine products.
North America accounted for the largest share of the vaccines market with its well-established vaccination program. In addition, factors such as the increasing prevalence of diseases, growing adoption of advanced vaccines, and large pool of key players are further expected to propel the growth of vaccines market in this region.
In 2017, the pneumococcal disease accounted for the largest share of the global vaccines market. The large share of this segment is mainly attributed to the high prevalence of pneumococcal disease in pediatric, elderly, and immunocompromised populations.
The intramuscular accounted for the largest share of the vaccines market. The large share of this segment is mainly due to the availability of wide range of vaccines for IM.
Key Topics Covered in This Report:
Introduction
Research Methodology
Executive Summary
Market Share Analysis
Market Insights
Global Vaccines Market, by Indication
Global Vaccines Market, by Route of Administration
Global Vaccines Market, by Type/Antigen
Global Vaccines Market, by Valence
Vaccines Market, by Region
Competitive Landscape
Company Profiles
Appendix
Get Free sample report here: https://www.meticulousresearch.com/download-sample-report/?cp_id=4813
Vaccines Market by Indication (Pneumococcal, Influenza, DTP, HPV, Hepatitis, Meningococcal, Rotavirus, Polio, MMR), Type (Live, Toxoid), Route of Administration (IM, SC, Oral), Valence (Monovalent, Multivalent) And Geography – Global Forecast To 2025
Browse detailed TOC @ https://www.meticulousresearch.com/product/vaccines-market/
The global vaccines market is highly competitive with the presence of many players worldwide. With four big pharmaceutical companies; GSK, Merck & Co., Inc., Pfizer, and Sanofi, the vaccine industry is highly consolidated. CSL Limited, Emergent Biosolutions, Johnson and Johnson, Serum Institute of India, Daiichi Sankyo, Takeda and AstraZeneca are the other leading players of the global vaccines market. All these players are focusing more on technologically-advanced vaccine products.
North America accounted for the largest share of the vaccines market with its well-established vaccination program. In addition, factors such as the increasing prevalence of diseases, growing adoption of advanced vaccines, and large pool of key players are further expected to propel the growth of vaccines market in this region.
In 2017, the pneumococcal disease accounted for the largest share of the global vaccines market. The large share of this segment is mainly attributed to the high prevalence of pneumococcal disease in pediatric, elderly, and immunocompromised populations.
The intramuscular accounted for the largest share of the vaccines market. The large share of this segment is mainly due to the availability of wide range of vaccines for IM.
Key Topics Covered in This Report:
Introduction
Research Methodology
Executive Summary
Market Share Analysis
Market Insights
Global Vaccines Market, by Indication
Global Vaccines Market, by Route of Administration
Global Vaccines Market, by Type/Antigen
Global Vaccines Market, by Valence
Vaccines Market, by Region
Competitive Landscape
Company Profiles
Appendix
Get Free sample report here: https://www.meticulousresearch.com/download-sample-report/?cp_id=4813
Contact Information:
Meticulous Research™
Viren
Tel: +91 744-7780008
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Meticulous Research™
Viren
Tel: +91 744-7780008
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results